Evidence map›Paper›PMID 26170993›Full record

ArticleOncology letters2015

Recurrent 12q13-15 chromosomal aberrations, high frequency of isocitrate dehydrogenase 1 mutations, and absence of high mobility group AT-hook 2 expression in periosteal chondromas.

Ioannis Panagopoulos, Ludmila Gorunova, Ingeborg Taksdal, Bodil Bjerkehagen, Sverre Heim

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ioannis PanagopoulosSection for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo 0424, Norway ; Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo 0316, Norway.
Ludmila GorunovaSection for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo 0424, Norway ; Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo 0316, Norway.
Ingeborg TaksdalDepartment of Radiology and Nuclear Medicine, The Norwegian Radium Hospital, Oslo University Hospital, Oslo 0424, Norway.
Bodil BjerkehagenDepartment of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo 0424, Norway.
Sverre HeimSection for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo 0424, Norway ; Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo 0316, Norway ; Faculty of Medicine, University of Oslo, Oslo 0316, Norway.
Oslo University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Periosteal chondroma is a benign cartilage tumor that accounts for <2% of chondromas. In the present study, four cases of periosteal chondromas were cytogenetically investigated and studied for the expression of high-mobility group AT-hook 2 (

Indexed as

12q13-15 chromosomal aberrationscytogeneticshigh-mobility group AT-hook 2isocitrate dehydrogenase 1 mutationsperiosteal chondromas

Identifiers

PMID26170993
PMCPMC4487192
OpenAlexW1598763741

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.